Isorhamnetin-3-O-nehesperidine

  Cat. No.:  DCY-075  
Chemical Structure
55033-90-4
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
>98%,Standard References
Cas No.: 55033-90-4
SMILES: O=C1C(O[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H]2O[C@@](O[C@@H](C)[C@H](O)[C@H]3O)([H])[C@@H]3O)=C(C4=CC(OC)=C(O)C=C4)OC5=CC(O)=CC(O)=C15
Formula: C28H32O16
M.Wt: 624.544090270996
Purity: >98%, Standard References Grade
Sotrage: 4°C for 1 year, -20°C for more than 2 years
Description: For the detailed information about the solubility of Isorhamnetin-3-O-nehesperidine in water, the solubility of Isorhamnetin-3-O-nehesperidine in DMSO, the solubility of Isorhamnetin-3-O-nehesperidine in PBS buffer, the animal experiment(test) of Isorhamnetin-3-O-nehesperidine,the in vivo,in vitro and clinical trial test of Isorhamnetin-3-O-nehesperidine,the cell experiment(test) of Isorhamnetin-3-O-nehesperidine,the IC50, EC50 and Affinity of Isorhamnetin-3-O-nehesperidine, please contact DC Chemicals.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DCC-003 Vincristine >98%,Standard References
DCZ-289 songorine purity >98%,Standard References
DCZ-286 8-GERANOPSORALEN purity >98%,Standard References
DCZ-290 Isobavachin purity >98%,Standard References
DCZ-292 TECTOCHRYSIN purity >98%,Standard References
DCZ-291 isorhapontigenin purity >98%,Standard References
DCZ-287 Protopine purity >98%,Standard References
DC8874 7-TACA Impurity D of Cefoperazone
DCQ-033 fraxin Fraxin is a coumarin glycoside that has been found in Fraxinus and has anti-inflammatory activity.
DC23085 Dihydrocapsaicin Dihydrocapsaicin, a potential inducer of autophagy, has cytotoxic activity. It has anti-atherogenic activity, can reduce the susceptibility of low-density lipoprotein (LDL) to oxidation. Dihydrocapsaicin treatment depletes peptidergic nerve fibers of subs
X